SARs in LPA: The 2-OH Moiety
81
lets without increasing [32P] labelling of phosphatidic acid. Biochim. Bio-
phys. Acta 795:487–492 (1984).
3. Tokumura, A., N. Yube, H. Fujimoto, and H. Tsukatani. Lysophosphatidic
acids induce contraction of rat isolated colon by two different mechanisms.
J. Pharm. Pharmacol. 43:774–778 (1991).
4. Tokumura, A., K. Fukuzawa, S. Yamada, and H. Tsukatani. Stimulatory
effect of lysophosphatidic acids on uterine smooth muscles of non-pregnant
rats. Arch. Int. Pharmacodyn. 245:74–83 (1980).
5. Jalink, K., E. J. van Corven, and W. H. Moolenaar. Lysophosphatidic acid,
but not phosphatidic acid, is a potent Ca2ϩ-mobilizing stimulus for fibro-
blasts. J. Biol. Chem. 65:12232–12239 (1990)
6. van Corven, E. J., A. van Rijswijk, K. Jalink, R. L. van der Bend, W. J. van
Blitterswijk, and W. H. Moolenaar. Mitogenic action of lysophosphatidic
acid and phosphatidic acid on fibroblasts. Biochem. J. 281:163–169 (1992).
7. Ridley, A. J., and A. Hall. The small GTP-binding protein rho regulates the
assembly of focal adhesions and actin stress fibers in response to growth
factors. Cell 70:389–399 (1992).
21. Kingsley, P. B., and G. W. Feigenson. The synthesis of a predeuterated
phospholipid: 1,2-dimyristoyl-sn-glycero-3-phosphocholine-d72. Chem.
Phys. Lipids 24:135–147 (1979).
22. Bannwarth, W., and A. Trzeciak. A simple and effective chemical phos-
phorylation procedure for biomolecules. Helv. Chim. Acta 70:175–186
(1987).
23. Durieux, M. E., S. J. Carlisle, M. N. Salafranca, and K. R. Lynch. Endog-
enous responses to sphingosine-1-phosphate in X. laevis oocytes: similar-
ities with lysophosphatidic acid signaling. Am. J. Physiol. 264:C1360–
C1364 (1993).
24. Lee, A., E. M. Talley, D. L. Rosin, and K. R. Lynch. Characterization of ␣2
adrenergic receptors in GT1 neurosecretory cells. Neuroendocrinology 62:
215–225 (1995).
25. Durieux, M. E., M. N. Salafranca, K. R. Lynch, and J. R. Moorman.
Lysophosphatidic acid induces a pertussis toxin-sensitive Ca2ϩ-activated
ClϪ current in Xenopus laevis oocytes. Am. J. Physiol. 263:C896—C900
(1992).
8. Plevin, R., E. E. MacNulty, S. Palmer, and M. J. O. Wakelam. Differences
in the regulation of endothelin-1- and lysophosphatidic-acid-stimulated
Ins(1,4,5)P3 formation in Rat fibroblasts. Biochem. J. 280:609–615 (1991).
9. Howe, L. R., and C. J. Marshall. Lysophosphatidic acid stimulates mito-
gen- activated protein kinase activation via a G protein-coupled pathway
requiring p21ras and p74raf-1. J. Biol. Chem. 268:20717–20720 (1993).
10. Kumagai, N., N. Morii, K. Fujisawa, Y. Nemoto, and S. Narumiya. ADP-
ribosylation of rho p21 inhibits lysophosphatidic acid- induced protein
tyrosine phosphorylation and phosphatidylinositol 3-kinase activation in
cultured Swiss 3T3 cells. J. Biol. Chem. 268:24535–24538 (1993).
11. Piazza, G. A., J. L. Ritter, and C. A. Baracka. Lysophosphatidic acid
induction of transforming growth factors a and b: modulation of prolifer-
ation and differentiation in cultured human keratinocytes and mouse skin.
Exp. Cell Res. 216:51–64 (1995).
12. Tokumura, A., M. Iimori, Y. Nishioka, M. Kitahara, M. Sakashita, and S.
Tanaka. Lysophosphatidic acids induce proliferation of cultured vascular
smooth muscle cells from rat aorta. Am. J. Physiol. 267:C204–C210 (1994).
13. Bashir, N., K. Kuhen, and M. Taub. Phospholipids regulate growth and
function of MDCK cells in hormonally defined serum free medium. In Vitro
28A:663–668 (1992).
14. Tigyi, G., and R. Miledi. Lysophosphatidates bound to serum albumin
activate membrane currents in Xenopus oocytes and neurite retraction in
PC12 pheochromocytoma cells. J. Biol. Chem. 267:21360–21367 (1992).
15. Gerrard, J. M., and P. Robinson. Identification of the molecular species of
lysophosphatidic acid produced when platelets are stimulated by throm-
bin. Biochim. Biophys. Acta 1001:282–285 (1989).
16. Eichholtz, T., K. Jalink, I. Fahrenfort, and W. H. Moolenaar. The bioactive
phospholipid lysophosphatidic acid is released from activated platelets.
Biochem. J. 291:677–680 (1993).
26. Bittman, R., B. Swords, K. Liliom, and G. Tigyi. Inhibitors of lipid phos-
phatidate receptors: N-palmitoyl-serine and N-palmitoyl-tyrosine phos-
phoric acids. J. Lipid Res. 37:391–398 (1996).
27. Moolenaar, W. H. Lysophosphatidic acid signalling. Curr. Opin. Cell Biol.
7:203–210 (1995).
28. Durieux, M. E., and K. R. Lynch. Signalling properties of lysophosphatidic
acid. Trends Pharmacol. Sci. 14:249–254 (1993).
29. Sugiura, T., A. Tokumura, L. Gregory, T. Nouchi, S. T. Weintraub, and D.
J. Hanahan. Biochemical characterization of the interaction of lipid phos-
phoric acids with human platelets: comparison with platelet activating
factor. Arch. Biochem. Biophys. 311:358–368 (1994).
30. Simon, M.-F., H. Chap, and L. Douste-Blazy. Human platelet aggregation
induce of 1-alkyl-lysophosphatidic acid and its analogs: a new group of
phospholipid mediators. Biochem. Biophys. Res. Commun. 108:1743–1750
(1992).
31. van Corven, E. J., A. Groenink, K. Jalink, T. Eichholtz, and W. H.
Moolenaar. Lysophosphatidate-induced cell proliferation: identification
and dissection of signaling pathways mediated by G proteins. Cell 59:
45–54 (1989).
32. Bauer, P. H., A. T. Chiu, and J. C. Garrison. DuP 753 can antagonize the
affects of angiotensin II in rat liver. Mol. Pharmacol. 39:579–585 (1991).
33. Hung, D. T., Y. H. Wong, T. H. Vu, and S. R. Coughlin. The cloned platelet
thrombin receptor couples to at least two distinct effectors to stimulate
phosphoinositide hydrolysis and inhibit adenylyl cyclase. J. Biol. Chem.
267:20831–20834 (1992).
34. Devane, W. A., L. Hanus, A. Breuer, R. G. Pertwee, L. A. Stevenson, G.
Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam. Isola-
tion and structure of a brain constituent that binds to the cannabinoid
receptor. Science (Washington D. C.) 258:1946–1949 (1992).
35. Di Marzo, V., L. De Petrocellis, N. Sepe, and A. Buono. Biosynthesis of
anandamide and related acylethanolamides in mouse J774 macrophages
and N18 neuroblastoma cells. Biochem. J. 316:977–984 (1996).
36. Di Marzo, V., A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J. C.
Schwartz, and D. Piomelli. Formation and inactivation of endogenous
cannabinoid anandamide in central neurons. Nature (Lond.) 372:686–691
(1994).
17. Xu, Y., D. C. Gaudette, J. D. Boynton, A. Frankel, X. J. Fang, A. Sharma,
J. Hurteau, G. Casey, A Goodbody, A. Mellors, B. J. Holub, and G. B. Mills.
Characterization of an ovarian cancer activating factor in ascites from
ovarian cancer patients. Clin. Cancer Res. 1:1223–1232 (1996).
18. Tigyi, G., L. Hong, M. Yakubu, H. Parfenova, M. Shibata, and C. W.
Leffler. Lysophosphatidic acid alters cerebrovascular reactivity in piglets.
Am. J. Physiol. 268:H2048–H2055 (1995).
19. Tokumura, A., K. Fukuzawa, and H. Tsukatani. Effects of synthetic and
natural lysophosphatidic acids on the arterial blood pressure of different
animal species. Lipids 13:572–574 (1978).
20. Jalink, K., T. Hengeveld, S. Mulder, F. R. Postma, M. F. Simon, H. Chap,
G. A. van der Marel, J. H. van Boom, W. J. van Blitterswijk, and W. H.
Moolenaar. Lysophosphatidic acid-induced Ca2ϩ mobilization in human
A431 cells: structure-activity analysis. Biochem. J. 307:609–616 (1995).
Send reprint requests to: Kevin R. Lynch, Ph.D., Department of Pharma-
cology, Box 448, University of Virginia Health Sciences Center, 1300 Jefferson
Park Avenue, Charlottesville, VA 22908. E-mail: krl2z@virginia.edu